ASND logo

Ascendis Pharma A/S (ASND) Cash From Operations

Annual CFO:

-$331.21M+$174.06M(+34.45%)
December 31, 2024

Summary

  • As of today, ASND annual cash from operations is -$331.21 million, with the most recent change of +$174.06 million (+34.45%) on December 31, 2024.
  • During the last 3 years, ASND annual cash from operations has risen by +$162.44 million (+32.91%).
  • ASND annual cash from operations is now -4053.67% below its all-time high of $8.38 million, reached on December 31, 2013.

Performance

1-Year Change

+34.45%

3-Year Change

+32.91%

5-Year Change

-68.2%

15-Year Change

-208.78%

ASND Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

2.1%
ASND annual cash from operations is higher than 2.1% of companies in Healthcare sector

Range

All-Time High

$8.38M
ASND annual cash from operations is currently -4053.67% below its historical high of $8.38 million

3-Year Low

-$520.97M
ASND annual cash from operations is currently +36.42% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ASND previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 11, 2026
ASND next annual earnings announcement is scheduled for Feb 11, 2026

OtherASNDcash flow metrics

Annual CFI

$7.44M
ASND annual cash from investing is $7.44 million

Annual CFF

$480.19M
ASND annual cash from financing is $480.19 million

Annual FCF

-$332.75M
ASND annual free cash flow is -$332.75 million

Annual CAPEX

$1.54M
ASND annual capital expenditures is $1.54 million

Quarterly CFO:

$1.57M+$10.04M(+118.50%)
September 30, 2025

Summary

  • As of today, ASND quarterly cash from operations is $1.57 million, with the most recent change of +$10.04 million (+118.50%) on September 30, 2025.
  • Over the past year, ASND quarterly cash from operations has increased by +$62.93 million (+102.56%).
  • ASND quarterly cash from operations is now -88.95% below its all-time high of $14.20 million, reached on September 1, 2013.

Performance

3-Month Change

+118.5%

1-Year Change

+102.56%

3-Year Change

+101.61%

5-Year Change

+102.32%

ASND Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

73.25%
ASND quarterly cash from operations is higher than 73.25% of companies in Healthcare sector

Range

All-Time High

$14.20M
ASND quarterly cash from operations is currently -88.95% below its historical high of $14.20 million

3-Year Low

-$167.47M
ASND quarterly cash from operations is currently +100.94% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ASND previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 11, 2026
ASND next earnings announcement is scheduled for Feb 11, 2026

OtherASNDcash flow metrics

Quarterly CFI

-$259.40K
ASND quarterly cash from investing is -$259.40 thousand

Quarterly CFF

$43.34M
ASND quarterly cash from financing is $43.34 million

Quarterly FCF

$1.31M
ASND quarterly free cash flow is $1.31 million

Quarterly CAPEX

$259.40K
ASND quarterly capital expenditures is $259.40 thousand

TTM CFO:

-$117.69M+$62.93M(+34.84%)
September 30, 2025

Summary

  • As of today, ASND TTM cash from operations is -$117.69 million, with the most recent change of +$62.93 million (+34.84%) on September 30, 2025.
  • Over the past year, ASND TTM cash from operations has increased by +$159.29 million (+57.51%).
  • ASND TTM cash from operations is now -928.98% below its all-time high of $14.20 million, reached on September 1, 2013.

Performance

3-Month Change

+34.84%

1-Year Change

+57.51%

3-Year Change

+77.31%

5-Year Change

+54.35%

ASND TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

12.06%
ASND TTM cash from operations is higher than 12.06% of companies in Healthcare sector

Range

All-Time High

$14.20M
ASND TTM cash from operations is currently -928.98% below its historical high of $14.20 million

3-Year Low

-$602.42M
ASND TTM cash from operations is currently +80.46% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ASND previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 11, 2026
ASND next earnings announcement is scheduled for Feb 11, 2026

OtherASNDcash flow metrics

TTM CFI

-$6.13M
ASND TTM cash from investing is -$6.13 million

TTM CFF

$33.27M
ASND TTM cash from financing is $33.27 million

TTM FCF

-$123.89M
ASND TTM free cash flow is -$123.89 million

TTM CAPEX

$6.20M
ASND TTM capital expenditures is $6.20 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ASND Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+34.5%+102.6%+57.5%
3Y3 Years+32.9%+101.6%+77.3%
5Y5 Years-68.2%+102.3%+54.4%

ASND Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+36.4%at high+100.9%at high+80.5%
5Y5-Year-68.2%+36.4%at high+100.9%at high+80.5%
All-TimeAll-Time-4053.7%+36.4%-89.0%+100.9%-929.0%+80.5%

ASND Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.57M(+118.5%)
-$117.69M(+34.8%)
Jun 2025
-
-$8.48M(+43.7%)
-$180.62M(+24.1%)
Mar 2025
-
-$15.06M(+84.3%)
-$237.82M(+28.6%)
Dec 2024
-$331.21M(+34.4%)
-$95.72M(-56.0%)
-$333.01M(-20.2%)
Sep 2024
-
-$61.36M(+6.6%)
-$276.98M(+21.5%)
Jun 2024
-
-$65.68M(+40.4%)
-$352.63M(+22.4%)
Mar 2024
-
-$110.25M(-177.8%)
-$454.42M(+9.5%)
Dec 2023
-$505.27M(+3.0%)
-$39.69M(+71.0%)
-$501.94M(+16.7%)
Sep 2023
-
-$137.00M(+18.2%)
-$602.42M(-7.0%)
Jun 2023
-
-$167.47M(-6.2%)
-$562.81M(-6.6%)
Mar 2023
-
-$157.77M(-12.6%)
-$528.13M(-2.1%)
Dec 2022
-$520.97M(-5.5%)
-$140.17M(-43.9%)
-$517.08M(+0.3%)
Sep 2022
-
-$97.40M(+26.7%)
-$518.68M(+3.4%)
Jun 2022
-
-$132.79M(+9.5%)
-$536.67M(+1.1%)
Mar 2022
-
-$146.72M(-3.5%)
-$542.60M(-9.8%)
Dec 2021
-$493.65M(-59.5%)
-$141.77M(-22.9%)
-$494.19M(-7.8%)
Sep 2021
-
-$115.39M(+16.8%)
-$458.60M(-11.7%)
Jun 2021
-
-$138.71M(-41.1%)
-$410.66M(-22.8%)
Mar 2021
-
-$98.31M(+7.4%)
-$334.29M(-8.0%)
Dec 2020
-$309.56M(-57.2%)
-$106.18M(-57.4%)
-$309.56M(-20.1%)
Sep 2020
-
-$67.46M(-8.2%)
-$257.79M(-0.1%)
Jun 2020
-
-$62.34M(+15.3%)
-$257.44M(-28.0%)
Mar 2020
-
-$73.58M(-35.2%)
-$201.08M(-2.1%)
DateAnnualQuarterlyTTM
Dec 2019
-$196.92M(-20.3%)
-$54.41M(+18.9%)
-$196.92M(-7.1%)
Sep 2019
-
-$67.10M(-1021.1%)
-$183.86M(-7.5%)
Jun 2019
-
-$5.99M(+91.4%)
-$171.11M(+9.3%)
Mar 2019
-
-$69.41M(-67.8%)
-$188.72M(-14.8%)
Dec 2018
-$163.75M(-52.7%)
-$41.36M(+23.9%)
-$164.46M(-7.8%)
Sep 2018
-
-$54.35M(-130.3%)
-$152.50M(-19.3%)
Jun 2018
-
-$23.60M(+47.7%)
-$127.87M(+1.6%)
Mar 2018
-
-$45.15M(-53.6%)
-$129.93M(-21.1%)
Dec 2017
-$107.27M(-61.1%)
-$29.39M(+1.1%)
-$107.33M(-11.1%)
Sep 2017
-
-$29.72M(-15.8%)
-$96.60M(-14.8%)
Jun 2017
-
-$25.66M(-13.8%)
-$84.17M(-15.1%)
Mar 2017
-
-$22.55M(-20.8%)
-$73.16M(-9.2%)
Dec 2016
-$66.57M(-38.1%)
-$18.67M(-8.0%)
-$67.00M(-12.6%)
Sep 2016
-
-$17.29M(-18.1%)
-$59.50M(-41.0%)
Jun 2016
-
-$14.64M(+10.7%)
-$42.21M(-53.1%)
Mar 2016
-
-$16.40M(-46.9%)
-$27.57M(-146.9%)
Dec 2015
-$48.20M(-97.5%)
-$11.17M(-13.6%)
-$11.17M(+54.3%)
Dec 2014
-$24.41M(-391.4%)
-$9.83M(-118.5%)
-$24.41M(-33.4%)
Sep 2014
-
-$4.50M(+32.0%)
-$18.30M(-4740.1%)
Jun 2014
-
-$6.61M(-90.7%)
$394.40K(-94.4%)
Mar 2014
-
-$3.47M(+6.8%)
$7.01M(-33.1%)
Dec 2013
$8.38M(+1100.3%)
-$3.72M(-126.2%)
$10.48M(-26.2%)
Sep 2013
-
$14.20M
$14.20M
Dec 2012
-$837.50K
-
-

FAQ

  • What is Ascendis Pharma A/S annual cash from operations?
  • What is the all-time high annual cash from operations for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual cash from operations year-on-year change?
  • What is Ascendis Pharma A/S quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S quarterly cash from operations year-on-year change?
  • What is Ascendis Pharma A/S TTM cash from operations?
  • What is the all-time high TTM cash from operations for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S TTM cash from operations year-on-year change?

What is Ascendis Pharma A/S annual cash from operations?

The current annual cash from operations of ASND is -$331.21M

What is the all-time high annual cash from operations for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual cash from operations is $8.38M

What is Ascendis Pharma A/S annual cash from operations year-on-year change?

Over the past year, ASND annual cash from operations has changed by +$174.06M (+34.45%)

What is Ascendis Pharma A/S quarterly cash from operations?

The current quarterly cash from operations of ASND is $1.57M

What is the all-time high quarterly cash from operations for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly cash from operations is $14.20M

What is Ascendis Pharma A/S quarterly cash from operations year-on-year change?

Over the past year, ASND quarterly cash from operations has changed by +$62.93M (+102.56%)

What is Ascendis Pharma A/S TTM cash from operations?

The current TTM cash from operations of ASND is -$117.69M

What is the all-time high TTM cash from operations for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high TTM cash from operations is $14.20M

What is Ascendis Pharma A/S TTM cash from operations year-on-year change?

Over the past year, ASND TTM cash from operations has changed by +$159.29M (+57.51%)
On this page